Cited by 10Advancements in Transdermal Drug DeliveryDermatologic Treatments and ResearchSkin Protection and Aging

Microneedles: A novel clinical technology for evaluating skin characteristics

Open access
Kim, Seo Hyeong, Kim, Ji Hye, Choi, Yoon Mi, Seo, Su Min, Jang, Eun Young, Lee, Sung Jae, Cho, Suhyun, Jeong, Do Hyeon +1 more·2024·Skin Research and Technology

Abstract

Background: Current methods for evaluating efficacy of cosmetics have limitations because they cannot accurately measure changes in the dermis. Skin sampling using microneedles allows identification of skin‐type biomarkers, monitoring treatment for skin inflammatory diseases, and evaluating efficacy of anti‐aging and anti‐pigmentation products. Materials and methods: Two studies were conducted: First, 20 participants received anti‐aging treatment; second, 20 participants received anti‐pigmentation treatment. Non‐invasive devices measured skin aging (using high‐resolution 3D‐imaging in the anti‐aging study) or pigmentation (using spectrophotometry in the anti‐pigmentation study) at weeks 0 and 4, and adverse skin reactions were monitored. Skin samples were collected with biocompatible microneedle patches. Changes in expression of biomarkers for skin aging and pigmentation were analyzed using qRT‐PCR. Results: No adverse events were reported. In the anti‐aging study, after 4 weeks, skin roughness significantly improved in 17 out of 20 participants. qRT‐PCR showed significantly increased expression of skin‐aging related biomarkers: PINK1 in 16/20 participants, COL1A1 in 17/20 participants, and MSN in 16/20 participants. In the anti‐pigmentation study, after 4 weeks, skin lightness significantly improved in 16/20 participants. qRT‐PCR showed significantly increased expression of skin‐pigmentation‐related biomarkers: SOD1 in 15/20 participants and Vitamin D Receptor (VDR) in 15/20 participants. No significant change in TFAP2A was observed. Conclusion: Skin sampling and mRNA analysis for biomarkers provides a novel, objective, quantitative method for measuring changes in the dermis and evaluating the efficacy of cosmetics. This approach complements existing evaluation methods and has potential application in assessing the effectiveness of medical devices, medications, cosmeceuticals, healthy foods, and beauty devices.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/srt.13647

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Kim et al.73's study has limitations including small sample size and need for further research to validate findings on larger scale.

    “Limitations include the small sample size and the necessity for further research to validate the findings on a larger scale.”

    From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [73]

    The Materials and Methods section (Study participants; page not provided) reports 20 participants in each of two studies, supporting the small-sample-size point. The passages found do not state that larger-scale research is necessary to validate the findings; the Conclusion instead discusses potential applications. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • Kim et al.73 introduced a method using biocompatible microneedles and transcriptomics to objectively evaluate cosmeceutical efficacy.

    “A noteworthy recent study by Kim et al.73 presents an innovative approach to objectively evaluate the efficacy of cosmeceuticals. Their method involves analyzing skin samples collected using biocompatible microneedles and conducting transcriptomics analysis.”

    From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [73]

  • In Kim et al.73's two trials (20 participants each), results demonstrated improvements in skin roughness and lightness with significant changes in expression of biomarkers associated with skin aging and pigmentation.

    “Two trials were conducted, one focusing on anti‐aging and the other on anti‐pigmentation, each involving 20 participants. The results demonstrated improvements in skin roughness and lightness, accompanied by significant changes in the expression of biomarkers associated with skin aging and pigmentation.”

    From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [73]

  • Kim et al.73's study provides Level II evidence according to Oxford evidence hierarchy.

    “This study provides Level II evidence according to the Oxford evidence hierarchy, indicating moderate quality evidence.”

    From Cosmeceuticals in photoaging: A review. (2024) · cites this paper as [73]

    The Materials and Methods section describes two 20-participant studies with measurements at weeks 0 and 4. Our copy does not assign the study a Level II rating under the Oxford evidence hierarchy or call its evidence moderate quality (searched: Oxford evidence hierarchy, Level II, study design). (LLM, conf=0.78)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kim, S. H., Kim, J. H., Choi, Y. M., Seo, S. M., Jang, E. Y., Lee, S. J., Cho, S., Jeong, D. H., & Lee, K. H.
Affiliations
  • Cutis Biomedical Research Center Co. Ltd. Seoul Republic of Korea
  • Yonsei BB Skin Clinic Seoul Republic of Korea
  • Raphas Co. Ltd. Seoul Republic of Korea
Venue
Skin Research and Technology
Publisher
Wiley
Published
2024-03
Volume
30
Issue
3
Pages
e13647-e13647
ISSN
  • 0909-752X (ISSN-L)
  • 1600-0846
OpenAlex
W4392660889
Cited by
10
References
58
Citations by year
2026: 3 · 2025: 4 · 2024: 3
FWCI
1.74
Type
journal article
Language
en
Open access
Locations
  • Skin Research and Technology (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advancements in Transdermal Drug Delivery
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Health Sciences › Medicine › Dermatology › Skin Protection and Aging
Keywords
microneedles, skin sampling, skin aging, skin pigmentation, anti-aging cosmetics, skin biomarkers, PINK1, COL1A1, SOD1, vitamin D receptor, skin roughness, skin lightness, adverse skin reactions, microneedle patch, 3D skin imaging, spectrophotometry
MeSH terms
Cosmetics, Humans, Pigmentation Disorders, Skin, Skin Pigmentation, Biomarkers, Skin Aging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review